The Perils of Overly Sensitive Viral Load Testing for Persons With Human Immunodeficiency Virus.

The concept of "undetectable = untransmittable (U = U)" has been revolutionary in both the prevention and treatment of persons with human immunodeficiency virus (HIV). Most studies proving the concept of U = U used an HIV RNA (viral load [VL]) cutoff of 200 copies/mL to define being undetectable. Since then, increasingly sensitive commercial VL assays, sometimes down to a lower limit of detection (LLD) of 20 copies/mL, lead to confusion about the definition of "undetectable" and when someone is truly considered untransmittable. VLs between the LLD and 200 copies/mL have been associated with future virologic failure; however, no data exist to suggest that intervening in those patients leads to any meaningful benefits. In the absence of a demonstrable benefit of reporting such low VLs, we view this practice as harmful. We suggest recommendations for adjusting VL reporting and improving provider counseling, and call for research designs to mitigate the harms of overly sensitive VL testing.

Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey.

BACKGROUND: Despite the proven efficacy of medications for opioid use disorder (MOUD) and recent reduction in barriers to prescribers, numerous obstacles exist for patients seeking MOUD. Prior studies have used telephone surveys to investigate pharmacy-related barriers to MOUD. We applied this methodology to evaluate inpatient and outpatient pharmacy barriers to MOUD in South Florida. METHODS: Randomly selected pharmacies in South Florida (Miami-Dade, Broward, and Palm Beach Counties) were called using a standardized script with a "secret shopper" approach until 200 successful surveys had been completed. The primary outcome was the availability of any buprenorphine products. Second, a list of all 48 acute care hospitals within the aforementioned counties was compiled, and hospitals were contacted by telephone using a second structured script. RESULTS: A total of 1374 outpatient pharmacies and 48 inpatient pharmacies were identified. 378 randomly selected outpatient pharmacies were contacted to accrue 200 successful calls (53% success rate). All 48 inpatient pharmacies were contacted to successfully complete 25 inpatient surveys (52%). Of the 200 outpatient pharmacies contacted, 38% had any buprenorphine available. There was a significant difference in buprenorphine availability by county, with Miami-Dade having the least availability and Palm Beach having the most availability (27% vs. 47%, respectively; p = 0.04). Of the 38% with buprenorphine available, 82% had a sufficient supply for a two-week prescription of buprenorphine 8 mg twice daily. Of the pharmacies that did not have buprenorphine, 55% would be willing to order with a median estimated time to receive an order of 2 days (IQR 1.25-3 days). Of the 25 surveyed inpatient pharmacies, 88% reported having buprenorphine on inpatient formulary, and 55% of hospitals had at least one restriction on ordering of buprenorphine beyond federal regulations. CONCLUSIONS: The results of this study highlight significant pharmacy-related barriers to comprehensive OUD treatment across the healthcare system including both acute care hospital pharmacies and outpatient community pharmacies. Despite efforts to increase the number of MOUD providers, there still remain downstream obstacles to MOUD access.

Predictors of Successful Extubation in Neurocritical Care Patients.

INTRODUCTION: Delayed extubation in neurocritical care patients is associated with an increased length of stay in the intensive care unit (ICU), a greater incidence of ventilator-associated pneumonia (VAP), and a poor outcome. There is no evidence available to support use of certain variables over others as predictors of successful extubation in these patients. OBJECTIVE: This study aimed to identify predictors of successful extubation. MATERIAL AND METHODS: This was a prospective observational study. The following variables were recorded: neurocritical diagnosis, age, sex, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, Sequential Organ Failure Assessment (SOFA) score, duration of stay in the ICU, duration of mechanical ventilation, Airway Care Score (ACS), airway occlusion pressure/maximum inspiratory pressure (P 0.1/PIMAx), and the motor score component of the Glasgow Coma Scale (GCS) score. Weaning was defined as successful extubation and absence of ventilatory support for >7 days. RESULTS: In this prospective cohort of consecutive neurocritical care patients treated over a period of 30 months, we evaluated the following parameters daily: neurological status, intubation status, ventilator parameters, and gas exchange. Of 82 patients, 48 were excluded from the analysis and the remaining 34 patients were included in the analysis. A total of 26 participants (73.5%) achieved successful extubation. Their average age was 39.72 ± 16.43 years. None of the variables that were compared in relation to success or failure of extubation showed statistical significance, except for age (Z = -2.014, P < 0.044 with a Wide confidence interval; Spearman's ρ: r = 0.351, P < 0.042). CONCLUSION: In this study, the only predictive factor for successful extubation in neurocritical care patients was an age of <42.5 years.

Where Does the Peanut Smut Pathogen, Thecaphora frezii, Fit in the Spectrum of Smut Diseases?

Smut fungi, such as Ustilago maydis, have been studied extensively as a model for plant-pathogenic basidiomycetes. However, little attention has been paid to smut diseases of agronomic importance that are caused by species of the genus Thecaphora, probably due to their more localized distribution. Peanut smut incited by Thecaphora frezii has been reported only in South America, and Argentina is the only country where this disease has been noted in commercial peanut production. In this work, important advances in deciphering T. frezii specific biology/pathobiology in relation to potato (T. solani), wheat (U. tritici), and barley (U. nuda) smuts are presented. We summarize the state of knowledge of fungal effectors, functionally characterized to date in U. maydis and most recently in T. thlaspeos, as well as the potential to be present in other Thecaphora species involved in dicot-host interactions like T. frezii-peanut. We also discuss applicability and limitations of currently available methods for identification of smut fungi in different situations and management strategies to reduce their impact on agri-food quality. We conclude by describing some of the challenges in elucidating T. frezii strategies that allow it to infect the host and tolerate or evade plant immune defense mechanisms, and assessing other aspects related to pest control and their implications for human health.

Abdominal Supracervical Hysterectomy With Bilateral Salpingo-Oophorectomy as the Surgical Approach for a 22-Week Uterus With Incidental Endometrial Polyp Focal Atypia.

A 49-year-old perimenopausal female presented with abnormal uterine bleeding (AUB) and chronic lower abdominal pain with associated urinary urgency. The patient elected to have an abdominal supracervical hysterectomy with bilateral salpingo-oophorectomy for a large, symptomatic fibroid uterus. Preoperative ultrasounds revealed a uterine size of 22 x 20 x 17 cm and a 15.9 x 13 x 9 x 9.2 cm subserosal fibroid occupying the majority of the fundus and body of the uterus. Under general anesthesia, abdominal supracervical hysterectomy and bilateral salpingo-oophorectomy with a midline vertical incision were completed. Pathology reported a uterus with multiple leiomyomata as well as endometrial polyps with focal atypical endometrial hyperplasia and squamous metaplasia. Overall, the uterine corpus with one attached adnexa weighed 3433 g and was 25.8 x 20.3 x 15cm. Choice of surgical approach in a hysterectomy depends upon clinical circumstances, the surgeon's technical expertise, and patient preference. Although minimally invasive hysterectomies via vaginal and laparoscopic approaches are now preferred due to decreased hospitalization stays and postoperative recovering times, individualized treatment plans for patients should be considered depending on uterine size and the possibility of not achieving adequate exposure, which may lead to complications. As this case presents, an abdominal hysterectomy is an important option for certain patients where the use of other approaches could pose significant risk.

Safety and Efficacy With Augmented Second-Generation Perforated Pedicle Screws in Treating Degenerative Spine Disease in Elderly Population.

BACKGROUND: Degenerative spine disease is a common cause of low back pain in people age 65 years or older. Nonsurgical treatment is tried first, but if it is unsuccessful, surgery is advocated. This has special connotations for both underlying disease and the biomechanical characteristics of osteoporotic bone. We conducted an observational study to investigate the clinical and radiological outcome in patients in this age group with poor bone quality and degenerative lumbar instability treated with fusion using perforated pedicle screws augmented with polymethylmethacrylate (PMMA). METHODS: We collected prospective data on treatment, outcome, and patient characteristics from our institution's database. The primary outcome was a change in pain and physical function measured by the visual analog scale, the Core Outcome Measures Index, and the Oswestry Disability Index. Control participants were also analyzed for secondary complications such as hardware mobilization, fusion (as apparent on radiographs), and adjacent fractures or adjacent degenerative disc disease. RESULTS: We included 89 patients who underwent surgery between October 2015 and February 2018 at a mean age of 78 years (range, 67-88 years) and were then monitored for at least 12 months (range, 12-40 months). Findings on pain and function questionnaires showed improvement at 6 months after surgery, maintained at the final evaluation; 90% of patients had final score increases of ≥15 points. No patient developed clinical complications secondary to PMMA leakages. One patient had nonunion and screw breakage. No other patient had clinical or radiological nonunion. Of the control participants, 6 had adjacent disc disease, with 2 of them requiring instrumentation extension. Six deep infections required surgical revision without removal of material. CONCLUSION: PMMA-augmented cannulated pedicle screw instrumentation in spine fusion effectively and safely treats degenerative lumbar disease in patients who are age 65 years or older with poor bone quality.

Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling.

Hundreds of hormones and ligands stimulate cyclic AMP (cAMP) signaling in different tissues through the activation of G-protein-coupled receptors (GPCRs). Although the functions and individual effectors of cAMP signaling are well characterized in many tissues, pleiotropic effects of GPCR agonists limit investigations of physiological functions of cAMP signaling in individual cell types at different developmental stages in vivo To facilitate studies of cAMP signaling in specific cell populations in vivo, we harnessed the power of DREADD (designer receptors exclusively activated by designer drugs) technology by creating ROSA26-based knock-in mice for the conditional expression of a Gs-coupled DREADD (rM3Ds-green fluorescent protein [GFP], or "GsD"). After Cre recombinase expression, GsD is activated temporally by the administration of the ligand clozapine N-oxide (CNO). In the same allele, we engineered a CREB-luciferase reporter transgene for noninvasive bioluminescence monitoring of CREB activity. After viral delivery of Cre recombinase to hepatocytes in vivo, GsD is expressed and allows CNO-dependent cAMP signaling and glycogen breakdown. The long-term expression of GsD in the liver results in constitutive CREB activity and hyperglycemia. ROSA26-Gs-DREADD mice can be used to study the physiological effects of cAMP signaling, acute or chronic, in liver or any tissue or cell type for which transgenic or viral Cre drivers are available.

Correction: Knock-in Luciferase Reporter Mice for In Vivo Monitoring of CREB Activity.

[This corrects the article DOI: 10.1371/journal.pone.0158274.].

Knock-in Luciferase Reporter Mice for In Vivo Monitoring of CREB Activity.

The cAMP response element binding protein (CREB) is induced during fasting in the liver, where it stimulates transcription of rate-limiting gluconeogenic genes to maintain metabolic homeostasis. Adenoviral and transgenic CREB reporters have been used to monitor hepatic CREB activity non-invasively using bioluminescence reporter imaging. However, adenoviral vectors and randomly inserted transgenes have several limitations. To overcome disadvantages of the currently used strategies, we created a ROSA26 knock-in CREB reporter mouse line (ROSA26-CRE-luc). cAMP-inducing ligands stimulate the reporter in primary hepatocytes and myocytes from ROSA26-CRE-luc animals. In vivo, these animals exhibit little hepatic CREB activity in the ad libitum fed state but robust induction after fasting. Strikingly, CREB was markedly stimulated in liver, but not in skeletal muscle, after overnight voluntary wheel-running exercise, uncovering differential regulation of CREB in these tissues under catabolic states. The ROSA26-CRE-luc mouse line is a useful resource to study dynamics of CREB activity longitudinally in vivo and can be used as a source of primary cells for analysis of CREB regulatory pathways ex vivo.

Metástasis pulmonares en osterosarcoma neoadyuvancia, tratamiento quirúrgico y supervivencia / Pulmonary metastasis in osteosarcoma neoadjuvant, surgical treatment and survival

La supervivencia global a 5 años de los pacientes conosteosarcoma no-metastásico es del 60-70%, mientrasque la misma se reduce a 10-30% en los pacientes con enfermedad diseminada. El objetivo de nuestro estudiofue determinar supervivencia y factores pronósticos enun grupo de pacientes con metástasis pulmonares porosteosarcoma tratados quirúrgicamente. Se realizó unabúsqueda retrospectiva en nuestra base de datos oncológicaentre 1992-2006, y 38 pacientes fueron incluidos enel estudio. La edad media al momento del diagnóstico fuede 18 ± 9.4 años (3-45) y el seguimiento promedio de 57± 53.8 meses (12-231). Todos fueron tratados con quimioterapia, resección oncológica del tumor primario y de lasmetástasis pulmonares. Se analizó la supervivencia a 5 y10 años de la serie y los siguientes factores pronósticos: edad, sexo, localización del tumor primario, metástasis de inicio, recidiva local, número de metástasis extirpadasy la respuesta al tratamiento de quimioterapia (necrosistumoral). La supervivencia global fue de 29% a los 5 años(IC95%:14.5-43.5) y de 26% a los 10 años (IC95%:12-40).Se encontró una diferencia estadísticamente significativa entre los buenos y malos respondedores a la quimioterapia:53% (IC95%: 28-78) vs. 8% (IC95%: 0-20) (p = 0.0008). Nose observó relación estadísticamente significativa entre losdemás factores pronósticos analizados. La supervivenciaa 5 y 10 años de los pacientes con osteosarcoma y metástasis pulmonares tratados con quimioterapia y resección quirúrgica continúa siendo pobre. Los pacientes con buena respuesta a la quimioterapia neoadyuvante presentan un mejor pronóstico oncológico.

Five years overall survival in osteosarcoma patients isaround 70%, although in patients with metastatic diseaseit is only 10-30%. The objective of this study was to analyzeoverall survival and prognostic factors in a group of patientswith metastatic osteosarcoma treated with surgical removal of the lung metastases. A retrospective review from ouroncology data base revealed 38 patients treated between1992 and 2006. The mean age at diagnosis was 18 ± 9.4years (3-45) and mean follow-up was 57 ± 53.8 months(12-231). All patients were treated with chemotherapy and oncologic resection of the primary tumor and surgicalremoval of the lung metastases. We analyzed overallsurvival and prognostic factors: age, gender, site, time ofmetastasis, local recurrences, number of lung metastasisand chemotherapy response (necrosis). Overall survival of the entire series was 29% at 5 years (CI95%: 14.5-43.5)and 26% at 10 years (CI95%: 12-40). Significant differencein 5 year overall survival was found between good and badresponders to chemotherapy, 53% (IC95%: 28-78) vs. 8%(IC95%: 0-20) (p = 0.0008). No statistically significantrelationship between other prognostic factors analyzedwas observed. Five and ten years overall survival ratesin osteosarcoma patients with lung metastasis treatedwith chemotherapy and surgically resection is poor. Patientswith good response to chemotherapy have betterprognosis.

Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.

OBJECTIVE: Insulin resistance causes type 2 diabetes mellitus and hyperglycemia due to excessive hepatic glucose production and inadequate peripheral glucose uptake. Our objectives were to test the hypothesis that the proposed CREB/CRTC2 inhibitor salt inducible kinase 1 (SIK1) contributes to whole body glucose homeostasis in vivo by regulating hepatic transcription of gluconeogenic genes and also to identify novel SIK1 actions on glucose metabolism. METHODS: We created conditional (floxed) SIK1-knockout mice and studied glucose metabolism in animals with global, liver, adipose or skeletal muscle Sik1 deletion. We examined cAMP-dependent regulation of SIK1 and the consequences of SIK1 depletion on primary mouse hepatocytes. We probed metabolic phenotypes in tissue-specific SIK1 knockout mice fed high fat diet through hyperinsulinemic-euglycemic clamps and biochemical analysis of insulin signaling. RESULTS: SIK1 knockout mice are viable and largely normoglycemic on chow diet. On high fat diet, global SIK1 knockout animals are strikingly protected from glucose intolerance, with both increased plasma insulin and enhanced peripheral insulin sensitivity. Surprisingly, liver SIK1 is not required for regulation of CRTC2 and gluconeogenesis, despite contributions of SIK1 to hepatocyte CRTC2 and gluconeogenesis regulation ex vivo. Sik1 mRNA accumulates in skeletal muscle of obese high fat diet-fed mice, and knockout of SIK1 in skeletal muscle, but not liver or adipose tissue, improves insulin sensitivity and muscle glucose uptake on high fat diet. CONCLUSIONS: SIK1 is dispensable for glycemic control on chow diet. SIK1 promotes insulin resistance on high fat diet by a cell-autonomous mechanism in skeletal muscle. Our study establishes SIK1 as a promising therapeutic target to improve skeletal muscle insulin sensitivity in obese individuals without deleterious effects on hepatic glucose production.

[Osteosarcoma lung metastases. Survival after chemotherapy and surgery]. / Metástasis pulmonares en osteosarcoma. Neoadyuvancia, tratamiento quirúrgico y supervivencia.

Five years overall survival in osteosarcoma patients is around 70%, although in patients with metastatic disease it is only 10-30%. The objective of this study was to analyze overall survival and prognostic factors in a group of patients with metastatic osteosarcoma treated with surgical removal of the lung metastases. A retrospective review from our oncology data base revealed 38 patients treated between 1992 and 2006. The mean age at diagnosis was 18 ± 9.4 years (3-45) and mean follow-up was 57 ± 53.8 months (12-231). All patients were treated with chemotherapy and oncologic resection of the primary tumor and surgical removal of the lung metastases. We analyzed overall survival and prognostic factors: age, gender, site, time of metastasis, local recurrences, number of lung metastasis and chemotherapy response (necrosis). Overall survival of the entire series was 29% at 5 years (CI 95%: 14.5-43.5) and 26% at 10 years (CI 95%: 12-40). Significant difference in 5 year overall survival was found between good and bad responders to chemotherapy, 53% (IC 95%: 28-78) vs. 8% (IC 95%: 0-20) (p = 0.0008). No statistically significant relationship between other prognostic factors analyzed was observed. Five and ten years overall survival rates in osteosarcoma patients with lung metastasis treated with chemotherapy and surgically resection is poor. Patients with good response to chemotherapy have better prognosis.

Metástasis pulmonares en osteosarcoma neoadyuvancia, tratamiento quirúrgico y supervivencia

La supervivencia global a 5 años de los pacientes con osteosarcoma no-metastásico es del 60-70%, mientras que la misma se reduce a 10-30% en los pacientes con enfermedad diseminada. El objetivo de nuestro estudio fue determinar supervivencia y factores pronósticos en un grupo de pacientes con metástasis pulmonares por osteosarcoma tratados quirúrgicamente. Se realizó una búsqueda retrospectiva en nuestra base de datos oncológica entre 1992-2006, y 38 pacientes fueron incluidos en el estudio. La edad media al momento del diagnóstico fue de 18 ± 9.4 años (3-45) y el seguimiento promedio de 57 ± 53.8 meses (12-231). Todos fueron tratados con quimioterapia, resección oncológica del tumor primario y de las metástasis pulmonares. Se analizó la supervivencia a 5 y 10 años de la serie y los siguientes factores pronósticos: edad, sexo, localización del tumor primario, metástasis de inicio, recidiva local, número de metástasis extirpadas y la respuesta al tratamiento de quimioterapia (necrosis tumoral). La supervivencia global fue de 29% a los 5 años (IC95%:14.5-43.5) y de 26% a los 10 años (IC95%:12-40). Se encontró una diferencia estadísticamente significativa entre los buenos y malos respondedores a la quimioterapia: 53% (IC95%: 28-78) vs. 8% (IC95%: 0-20) (p = 0.0008). No se observó relación estadísticamente significativa entre los demás factores pronósticos analizados. La supervivencia a 5 y 10 años de los pacientes con osteosarcoma y metástasis pulmonares tratados con quimioterapia y resección quirúrgica continúa siendo pobre. Los pacientes con buena respuesta a la quimioterapia neoadyuvante presentan un mejor pronóstico oncológico.(AU)

Five years overall survival in osteosarcoma patients is around 70%, although in patients with metastatic disease it is only 10-30%. The objective of this study was to analyze overall survival and prognostic factors in a group of patients with metastatic osteosarcoma treated with surgical removal of the lung metastases. A retrospective review from our oncology data base revealed 38 patients treated between 1992 and 2006. The mean age at diagnosis was 18 ± 9.4 years (3-45) and mean follow-up was 57 ± 53.8 months (12-231). All patients were treated with chemotherapy and oncologic resection of the primary tumor and surgical removal of the lung metastases. We analyzed overall survival and prognostic factors: age, gender, site, time of metastasis, local recurrences, number of lung metastasis and chemotherapy response (necrosis). Overall survival of the entire series was 29% at 5 years (CI95%: 14.5-43.5) and 26% at 10 years (CI95%: 12-40). Significant difference in 5 year overall survival was found between good and bad responders to chemotherapy, 53% (IC95%: 28-78) vs. 8% (IC95%: 0-20) (p = 0.0008). No statistically significant relationship between other prognostic factors analyzed was observed. Five and ten years overall survival rates in osteosarcoma patients with lung metastasis treated with chemotherapy and surgically resection is poor. Patients with good response to chemotherapy have better prognosis.(AU)

Metástasis pulmonares en osteosarcoma neoadyuvancia, tratamiento quirúrgico y supervivencia

La supervivencia global a 5 años de los pacientes con osteosarcoma no-metastásico es del 60-70%, mientras que la misma se reduce a 10-30% en los pacientes con enfermedad diseminada. El objetivo de nuestro estudio fue determinar supervivencia y factores pronósticos en un grupo de pacientes con metástasis pulmonares por osteosarcoma tratados quirúrgicamente. Se realizó una búsqueda retrospectiva en nuestra base de datos oncológica entre 1992-2006, y 38 pacientes fueron incluidos en el estudio. La edad media al momento del diagnóstico fue de 18 ± 9.4 años (3-45) y el seguimiento promedio de 57 ± 53.8 meses (12-231). Todos fueron tratados con quimioterapia, resección oncológica del tumor primario y de las metástasis pulmonares. Se analizó la supervivencia a 5 y 10 años de la serie y los siguientes factores pronósticos: edad, sexo, localización del tumor primario, metástasis de inicio, recidiva local, número de metástasis extirpadas y la respuesta al tratamiento de quimioterapia (necrosis tumoral). La supervivencia global fue de 29% a los 5 años (IC95%:14.5-43.5) y de 26% a los 10 años (IC95%:12-40). Se encontró una diferencia estadísticamente significativa entre los buenos y malos respondedores a la quimioterapia: 53% (IC95%: 28-78) vs. 8% (IC95%: 0-20) (p = 0.0008). No se observó relación estadísticamente significativa entre los demás factores pronósticos analizados. La supervivencia a 5 y 10 años de los pacientes con osteosarcoma y metástasis pulmonares tratados con quimioterapia y resección quirúrgica continúa siendo pobre. Los pacientes con buena respuesta a la quimioterapia neoadyuvante presentan un mejor pronóstico oncológico.

Five years overall survival in osteosarcoma patients is around 70%, although in patients with metastatic disease it is only 10-30%. The objective of this study was to analyze overall survival and prognostic factors in a group of patients with metastatic osteosarcoma treated with surgical removal of the lung metastases. A retrospective review from our oncology data base revealed 38 patients treated between 1992 and 2006. The mean age at diagnosis was 18 ± 9.4 years (3-45) and mean follow-up was 57 ± 53.8 months (12-231). All patients were treated with chemotherapy and oncologic resection of the primary tumor and surgical removal of the lung metastases. We analyzed overall survival and prognostic factors: age, gender, site, time of metastasis, local recurrences, number of lung metastasis and chemotherapy response (necrosis). Overall survival of the entire series was 29% at 5 years (CI95%: 14.5-43.5) and 26% at 10 years (CI95%: 12-40). Significant difference in 5 year overall survival was found between good and bad responders to chemotherapy, 53% (IC95%: 28-78) vs. 8% (IC95%: 0-20) (p = 0.0008). No statistically significant relationship between other prognostic factors analyzed was observed. Five and ten years overall survival rates in osteosarcoma patients with lung metastasis treated with chemotherapy and surgically resection is poor. Patients with good response to chemotherapy have better prognosis.

Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano / Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions

Introducción. El síndrome de Guillain-Barré (SGB) es una urgencia neurológica que constituye la principal causa de parálisis flácida en el mundo, y que afecta a todos los grupos etarios. Se desconocen notablemente las características epidemiológicas esenciales del SGB en la mayor parte de los países de América Latina. Objetivo. Determinar la mortalidad asociada con el diagnóstico de SGB en altas hospitalarias efectuadas durante el año 2010 en instituciones de la Secretaría de Salud, México. Pacientes y métodos. Se analizó la base de datos de altas hospitalarias de instituciones que pertenecen a la Secretaría de Salud. Se identificaron los casos de SGB mediante el código G61.0 de la Clasificación Internacional de Enfermedades, 10.ª revisión (CIE-10). Se excluyeron los registros de pacientes menores de 18 años y los casos sin información demográfica completa. Resultados. Durante el año 2010 se registraron 2.634.339 altas de hospitales que pertenecen a la Secretaría de Salud. Se identificó un total de 467 hospitalizaciones por SGB en adultos (mediana de edad: 41 años; 62,1% hombres) de 121 instituciones sanitarias de los 32 estados federados de México. Durante el verano y otoño se registró la mayor frecuencia de hospitalizaciones por SGB. La mediana de la estancia hospitalaria fue de 8 días y la tasa de mortalidad hospitalaria, del 10,5%. La probabilidad de muerte se asoció directamente con la edad, sin una tendencia particular respecto al sexo, hospital de atención o entidad federativa. Conclusiones. En 2010, la mortalidad hospitalaria por SGB en esta parte del sistema sanitario mexicano fue más alta de la que se informa en estudios contemporáneos. Se observó una asociación estacional con la frecuencia de hospitalizaciones por SGB (AU)

Introduction. Guillain-Barré syndrome (GBS) is a neurological emergency representing the main cause of flaccid paralysis around the world, affecting all age groups. Little is known about the essential epidemiology of GBS in most Latin American countries. Aim. To determine the mortality associated with the diagnosis of GBS in hospital discharges during 2010 in hospitals of the Ministry of Health, Mexico. Patients and methods. We analyzed the database of hospital discharges of institutions pertaining to the Ministry of Health. Study cases were identified by the code G61.0 of the International Classification of Diseases, 10th revision (ICD-10). We excluded records of patients younger than 18 years and patients without complete demographic information. Results. During the year 2010 there were 2,634,339 discharges from hospitals of the Ministry of Health. We identified a total of 467 hospitalizations due to GBS in adults (median age: 41 years; 62.1% male) from 121 health institutions of the 32 Republic States. The highest frequency of GBS hospitalizations occurred during summer and fall. The median hospital stay was 8 days. The hospital mortality rate was 10.5%. The probability of death was directly associated with age, without a particular trend regarding gender, hospital care or state. Conclusions. In 2010 GBS hospital mortality in this part of the Mexican health system was higher than that reported in contemporary studies. A seasonal association was observed regarding the frequency of hospitalizations for GBS (AU)

[Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions]. / Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario Mexicano.

INTRODUCTION: Guillain-Barré syndrome (GBS) is a neurological emergency representing the main cause of flaccid paralysis around the world, affecting all age groups. Little is known about the essential epidemiology of GBS in most Latin American countries. AIM: To determine the mortality associated with the diagnosis of GBS in hospital discharges during 2010 in hospitals of the Ministry of Health, Mexico. PATIENTS AND METHODS: We analyzed the database of hospital discharges of institutions pertaining to the Ministry of Health. Study cases were identified by the code G61.0 of the International Classification of Diseases, 10th revision (ICD-10). We excluded records of patients younger than 18 years and patients without complete demographic information. RESULTS: During the year 2010 there were 2,634,339 discharges from hospitals of the Ministry of Health. We identified a total of 467 hospitalizations due to GBS in adults (median age: 41 years; 62.1% male) from 121 health institutions of the 32 Republic States. The highest frequency of GBS hospitalizations occurred during summer and fall. The median hospital stay was 8 days. The hospital mortality rate was 10.5%. The probability of death was directly associated with age, without a particular trend regarding gender, hospital care or state. CONCLUSIONS: In 2010 GBS hospital mortality in this part of the Mexican health system was higher than that reported in contemporary studies. A seasonal association was observed regarding the frequency of hospitalizations for GBS.

TITLE: Mortalidad asociada al diagnostico de sindrome de Guillain-Barre en adultos ingresados en instituciones del sistema sanitario mexicano.Introduccion. El sindrome de Guillain-Barre (SGB) es una urgencia neurologica que constituye la principal causa de paralisis flacida en el mundo, y que afecta a todos los grupos etarios. Se desconocen notablemente las caracteristicas epidemiologicas esenciales del SGB en la mayor parte de los paises de America Latina. Objetivo. Determinar la mortalidad asociada con el diagnostico de SGB en altas hospitalarias efectuadas durante el año 2010 en instituciones de la Secretaria de Salud, Mexico. Pacientes y metodos. Se analizo la base de datos de altas hospitalarias de instituciones que pertenecen a la Secretaria de Salud. Se identificaron los casos de SGB mediante el codigo G61.0 de la Clasificacion Internacional de Enfermedades, 10.ª revision (CIE-10). Se excluyeron los registros de pacientes menores de 18 años y los casos sin informacion demografica completa. Resultados. Durante el año 2010 se registraron 2.634.339 altas de hospitales que pertenecen a la Secretaria de Salud. Se identifico un total de 467 hospitalizaciones por SGB en adultos (mediana de edad: 41 años; 62,1% hombres) de 121 instituciones sanitarias de los 32 estados federados de Mexico. Durante el verano y otoño se registro la mayor frecuencia de hospitalizaciones por SGB. La mediana de la estancia hospitalaria fue de 8 dias y la tasa de mortalidad hospitalaria, del 10,5%. La probabilidad de muerte se asocio directamente con la edad, sin una tendencia particular respecto al sexo, hospital de atencion o entidad federativa. Conclusiones. En 2010, la mortalidad hospitalaria por SGB en esta parte del sistema sanitario mexicano fue mas alta de la que se informa en estudios contemporaneos. Se observo una asociacion estacional con la frecuencia de hospitalizaciones por SGB.

Distribución del bajo peso al nacer según algunas características de los territorios. Provincia de Cienfuegos, 1998 / Distribution of low birth weight according to some characteristics of the territory. Province of Cienfuegos, 1998

El análisis tradicional del índice de bajo peso al nacer en las provincias se realiza al nivel de municipios o áreas de salud, lo que muchas veces no permite identificar y localizar las zonas donde este indicador constituye un problema. Se presenta un estudio epidemiológico de tipo ecológico cuyos objetivos fundamentales son demostrar la existencia de diferencias en la interpretación del bajo peso al nacer según su distribución en diferentes espacios territoriales, y relacionar su índice con el tipo de población y la actividad económica predominantes del consejo popular. Se concluye que existen diferencias en la interpretación del bajo peso al nacer, según su distribución en diferentes espacios territoriales y que las diferencias del índice de bajo peso al nacer entre los consejos populares están asociadas con la actividad económica predominante, pero no con el tipo de población(AU)

Distribución del bajo peso al nacer según algunas características de los territorios. Provincia de Cienfuegos, 1998 / Distribution of low birth weight according to some characteristics of the territory. Province of Cienfuegos, 1998

El análisis tradicional del índice de bajo peso al nacer en las provincias se realiza al nivel de municipios o áreas de salud, lo que muchas veces no permite identificar y localizar las zonas donde este indicador constituye un problema. Se presenta un estudio epidemiológico de tipo ecológico cuyos objetivos fundamentales son demostrar la existencia de diferencias en la interpretación del bajo peso al nacer según su distribución en diferentes espacios territoriales, y relacionar su índice con el tipo de población y la actividad económica predominantes del consejo popular. Se concluye que existen diferencias en la interpretación del bajo peso al nacer, según su distribución en diferentes espacios territoriales y que las diferencias del índice de bajo peso al nacer entre los consejos populares están asociadas con la actividad económica predominante, pero no con el tipo de población